The most recent news and accomplishments of iBET are in the December edition of our Newsletter.
As part of iBET's People Development programme, the institute organised a 3-days course in Project Management addressed to iBET collaborators.
Paula Alves, CEO of iBET, was one of the members of the roundtable "Internationalization of R&D and Health Services"
New method to grow neural cells, that mimics aspects of the neuronal dysfunction associated with Mucopolysaccharidosis type VII, was recently described by iBET researchers in Scientific Reports.
Paula Alves, CEO of iBET and Professor at ITQB NOVA University was nominated member of the Scientific Committee of the Innovative Medicines Initiative (IMI).
We have now opened a new call for TRANSVAC Vaccine Development Services. The 4th cut-off date for proposal submission for the open TRANSVAC Call is on 15 December 2018.
We have now opened the 2nd call for TRANSVAC training module. Applications can be submitted until 1st November, 2018.
iBET recently received the visit of Prof Maria do Céu Machado and Prof Rui Ivo, President and Vice-President of Infarmed. An initiative of Bayer Portugal to show the research work at Bayer's satellite lab at iBET.
iBET receives the visit of Merck Global Health Institute for discussion of the collaborative project on Malaria26.09.2018
iBET was privileged to receive the visit of the Merck Global Health Institute and Merck Portugal, within the scope of the project "Developing a New Malaria Liver Stage Platform".
Structure of cancer related protein was described by iBET researchers, in a recently published paper in the journal Scientific Reports.